OUTCOME OF THE MEETING OF THE BOARD OF DIRECTORS OF PANCHSHEEL ORGANICS LIMITED HELD ON 30TH MAY 2025 FOR TEH APPROVAL OF FINAL ACCOUNTS FOR THE YEAR ENDED 31ST MARCH 2025.

Revenue declinedRelated-party transactionsResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.6%Reaction day

₹150.05

prior close

₹148.05

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%+1.5% vs market

Pharmaceuticals peers, median of 147sector-0.1%+1.8% vs sector

On the reaction day the stock moved 1.5 pts more than Nifty Microcap 250 and 1.8 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-4.0

10m

-2.7

15m

-2.3

30m

-2.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.6+0.1+1.5-0.1+1.8

Next day

+3.3-0.2+3.5-0.3+3.6

+3.3+0.3+3.0-0.3+3.6

+4.2+0.9+3.4+0.0+4.2

+3.3+0.8+2.5+0.0+3.3

+3.7+2.2+1.5+0.6+3.1

+0.6+3.4-2.8+1.4-0.8

15d

-8.0-0.8-7.2-2.9-5.1

-2.1+2.9-5.0+0.3-2.3

+18.6+0.8+17.8-0.5+19.1

+2.0+0.0+2.0-3.4+5.4

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 147Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Panchsheel Organics' board approved audited financial results for Q4 and FY ended March 31, 2025, with auditors (M/s. Jayesh R. Shah & Co.) issuing an unmodified opinion. Full-year revenue from operations rose marginally to Rs. 10,717.84 lakhs (~1.9% YoY), while net profit declined slightly to Rs. 1,379.45 lakhs from Rs. 1,410.76 lakhs. Q4 was weaker, with revenue falling ~9.3% YoY to Rs. 2,837.39 lakhs and PAT dropping ~13.6% to Rs. 317.12 lakhs. The board recommended a final dividend of Rs. 0.80 per share (on face value Rs. 10), approved related party transactions through omnibus approval for FY26, and appointed Talati and Associates as cost auditor and GMS & Co. as secretarial auditor (5-year term).

Likely market impact

Flat revenue growth and a softer Q4 with declining PAT signal margin pressure, though the unchanged Rs. 0.80 dividend and clean audit opinion provide stability for shareholders. Investors may watch operating cash flow, which fell sharply from Rs. 956.96 lakhs to Rs. 383.45 lakhs.